HC Wainwright Reaffirms Buy Rating for Edap Tms (NASDAQ:EDAP)

Edap Tms (NASDAQ:EDAP)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a report released on Friday,Benzinga reports. They currently have a $19.00 target price on the medical equipment provider’s stock. HC Wainwright also issued estimates for Edap Tms’ FY2029 earnings at $0.40 EPS.

Separately, StockNews.com initiated coverage on Edap Tms in a research report on Friday. They set a “hold” rating on the stock.

Edap Tms Stock Down 3.2 %

Shares of EDAP stock opened at $2.15 on Friday. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. Edap Tms has a twelve month low of $1.96 and a twelve month high of $8.50. The stock has a 50 day moving average of $2.42 and a 200 day moving average of $2.50. The stock has a market cap of $79.77 million, a P/E ratio of -3.31 and a beta of 0.37.

Edap Tms (NASDAQ:EDAP) last posted its earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.06. The firm had revenue of $22.69 million during the quarter, compared to analysts’ expectations of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. As a group, sell-side analysts expect that Edap Tms will post -0.6 EPS for the current year.

Institutional Investors Weigh In On Edap Tms

A number of institutional investors have recently added to or reduced their stakes in the stock. Parkman Healthcare Partners LLC acquired a new stake in shares of Edap Tms in the third quarter worth approximately $395,000. Jane Street Group LLC grew its holdings in Edap Tms by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after buying an additional 73,361 shares in the last quarter. Schonfeld Strategic Advisors LLC increased its stake in shares of Edap Tms by 48.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock worth $355,000 after acquiring an additional 52,500 shares during the last quarter. Millennium Management LLC raised its holdings in shares of Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after acquiring an additional 33,558 shares during the period. Finally, BNP Paribas Financial Markets boosted its position in shares of Edap Tms by 111.5% during the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 25,650 shares during the last quarter. Institutional investors and hedge funds own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.